FDA NDC Directory · JSON-LD · Markdown

Voraxaze

NDC 50633-210 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Generic nameglucarpidase
Labeler / ManufacturerBTG International Inc.
Marketing categoryBiologic License Application · App BLA125327
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAVENOUS
Active ingredientsGLUCARPIDASE (1000 [USP'U]/1)
Marketing started20120401
Package count1

External sources

Source: openFDA. Public-domain (CC0).